John Overdeck’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15M Sell
45,472
-2,900
-6% -$66K ﹤0.01% 3497
2026
Q1
$1.03M Buy
48,372
+8,700
+22% +$181K ﹤0.01% 3246
2025
Q4
$849K Hold
39,672
﹤0.01% 3042
2025
Q3
$665K Buy
+39,672
New +$595K ﹤0.01% 2842
2025
Q2
Sell
-31,328
Closed -$454K 3386
2025
Q1
$454K Sell
31,328
-54,615
-64% -$776K ﹤0.01% 2557
2024
Q4
$1.13M Sell
85,943
-23,482
-21% -$324K ﹤0.01% 2099
2024
Q3
$1.27M Sell
109,425
-64,255
-37% -$606K ﹤0.01% 1975
2024
Q2
$1.31M Buy
173,680
+93,424
+116% +$773K ﹤0.01% 1830
2024
Q1
$805K Sell
80,256
-197,465
-71% -$1.84M ﹤0.01% 2087
2023
Q4
$2.58M Buy
277,721
+37,999
+16% +$393K 0.01% 1347
2023
Q3
$3.05M Buy
239,722
+23,877
+11% +$328K 0.01% 1141
2023
Q2
$3.07M Buy
215,845
+134,836
+166% +$1.89M 0.01% 1174
2023
Q1
$1.21M Buy
+81,009
New +$1.23M ﹤0.01% 1765
2021
Q4
Sell
-70,231
Closed -$2M 4618
2021
Q3
$2M Buy
70,231
+30,023
+75% +$915K ﹤0.01% 1998
2021
Q2
$1.21M Sell
40,208
-92,319
-70% -$2.72M ﹤0.01% 2311
2021
Q1
$3.38M Sell
132,527
-113,361
-46% -$2.9M 0.01% 1312
2020
Q4
$6.03M Sell
245,888
-4,928
-2% -$92.5K 0.02% 822
2020
Q3
$4.08M Buy
250,816
+117,355
+88% +$2.18M 0.01% 895
2020
Q2
$2.28M Buy
133,461
+43,071
+48% +$639K 0.01% 1030
2020
Q1
$1.05M Sell
90,390
-285,035
-76% -$5.88M 0.01% 1369
2019
Q4
$10.4M Buy
375,425
+292,098
+351% +$7.32M 0.03% 602
2019
Q3
$1.89M Sell
83,327
-253,347
-75% -$5.77M 0.01% 1492
2019
Q2
$8.49M Buy
336,674
+126,010
+60% +$3.38M 0.03% 665
2019
Q1
$5.72M Buy
210,664
+109,274
+108% +$3.66M 0.02% 900
2018
Q4
$3.35M Buy
+101,390
New +$4.08M 0.01% 989
2017
Q4
Sell
-72,457
Closed -$3.12M 3314
2017
Q3
$3.12M Buy
+72,457
New +$3.44M 0.01% 1055
2014
Q1
Sell
-77,024
Closed -$4.11M 2152
2013
Q4
$4.11M Buy
+77,024
New +$4.13M 0.02% 699
2013
Q3
Sell
-153,192
Closed -$7.01M 1995
2013
Q2
$7.01M Buy
+153,192
New +$6.86M 0.05% 433

Other funds holding MD

John Overdeck's MD Position: Q2 2026 in Review

John Overdeck reduced its Pediatrix Medical (MD) stake by 6% in Q2 2026, selling an estimated $66K and leaving 45,472 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #3497.

John Overdeck first reported a position in MD in Q2 2013 and has held it in 28 quarters since. The position peaked at $10.4M in Q4 2019. 302 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • John Overdeck held 45,472 shares of Pediatrix Medical worth $1.15M as of Q2 2026.
  • John Overdeck sold 2,900 Pediatrix Medical shares in Q2 2026, an estimated $66K.
  • Pediatrix Medical made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #3497 holding.
  • John Overdeck first reported a position in Pediatrix Medical in Q2 2013 and has held it in 28 quarters since.
  • John Overdeck's Pediatrix Medical position peaked at $10.4M in Q4 2019.
  • 302 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.